Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

NCT00357500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Tumor, Pediatric
Leukemia
Lymphoma
Neuroblastoma
Sarcoma
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: celecoxib
DRUG: cyclophosphamide
DRUG: etoposide
DRUG: fenofibrate
DRUG: thalidomide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]